SRB17

N/A

Report date: 2024/08/01 10:15:40

Base Information

Drug NameSRB17
Drug Alias NameSRB17SRB-17
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Receptor tyrosine-protein kinase erbB-3
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSunRock Biopharma SL
China Registration ClassN/A

Develop Information

Active CompaniesSunRock Biopharma SL
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A